These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30256636)

  • 1. Antimalarial Lead-Optimization Studies on a 2,6-Imidazopyridine Series within a Constrained Chemical Space To Circumvent Atypical Dose-Response Curves against Multidrug Resistant Parasite Strains.
    Le Manach C; Paquet T; Wicht K; Nchinda AT; Brunschwig C; Njoroge M; Gibhard L; Taylor D; Lawrence N; Wittlin S; Eyermann CJ; Basarab GS; Duffy J; Fish PV; Street LJ; Chibale K
    J Med Chem; 2018 Oct; 61(20):9371-9385. PubMed ID: 30256636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Fast-Acting 2,6-Disubstituted Imidazopyridines That Are Efficacious in the in Vivo Humanized Plasmodium falciparum NODscidIL2Rγ
    Nchinda AT; Le Manach C; Paquet T; Gonzàlez Cabrera D; Wicht KJ; Brunschwig C; Njoroge M; Abay E; Taylor D; Lawrence N; Wittlin S; Jiménez-Díaz MB; Santos Martínez M; Ferrer S; Angulo-Barturen I; Lafuente-Monasterio MJ; Duffy J; Burrows J; Street LJ; Chibale K
    J Med Chem; 2018 May; 61(9):4213-4227. PubMed ID: 29665687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and
    Horatscheck A; Andrijevic A; Nchinda AT; Le Manach C; Paquet T; Khonde LP; Dam J; Pawar K; Taylor D; Lawrence N; Brunschwig C; Gibhard L; Njoroge M; Reader J; van der Watt M; Wicht K; de Sousa ACC; Okombo J; Maepa K; Egan TJ; Birkholtz LM; Basarab GS; Wittlin S; Fish PV; Street LJ; Duffy J; Chibale K
    J Med Chem; 2020 Nov; 63(21):13013-13030. PubMed ID: 33103428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent inhibitors of malarial P. Falciparum protein kinase G: Improving the cell activity of a series of imidazopyridines.
    Large JM; Birchall K; Bouloc NS; Merritt AT; Smiljanic-Hurley E; Tsagris DJ; Wheldon MC; Ansell KH; Coombs PJ; Kettleborough CA; Whalley D; Stewart LB; Bowyer PW; Baker DA; Osborne SA
    Bioorg Med Chem Lett; 2019 Feb; 29(3):509-514. PubMed ID: 30553738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial Imidazopyridazines.
    Le Manach C; Paquet T; Brunschwig C; Njoroge M; Han Z; Gonzàlez Cabrera D; Bashyam S; Dhinakaran R; Taylor D; Reader J; Botha M; Churchyard A; Lauterbach S; Coetzer TL; Birkholtz LM; Meister S; Winzeler EA; Waterson D; Witty MJ; Wittlin S; Jiménez-Díaz MB; Santos Martínez M; Ferrer S; Angulo-Barturen I; Street LJ; Chibale K
    J Med Chem; 2015 Nov; 58(21):8713-22. PubMed ID: 26502160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imidazolopiperazines: lead optimization of the second-generation antimalarial agents.
    Nagle A; Wu T; Kuhen K; Gagaring K; Borboa R; Francek C; Chen Z; Plouffe D; Lin X; Caldwell C; Ek J; Skolnik S; Liu F; Wang J; Chang J; Li C; Liu B; Hollenbeck T; Tuntland T; Isbell J; Chuan T; Alper PB; Fischli C; Brun R; Lakshminarayana SB; Rottmann M; Diagana TT; Winzeler EA; Glynne R; Tully DC; Chatterjee AK
    J Med Chem; 2012 May; 55(9):4244-73. PubMed ID: 22524250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification, Characterization, and Optimization of 2,8-Disubstituted-1,5-naphthyridines as Novel Plasmodium falciparum Phosphatidylinositol-4-kinase Inhibitors with in Vivo Efficacy in a Humanized Mouse Model of Malaria.
    Kandepedu N; Gonzàlez Cabrera D; Eedubilli S; Taylor D; Brunschwig C; Gibhard L; Njoroge M; Lawrence N; Paquet T; Eyermann CJ; Spangenberg T; Basarab GS; Street LJ; Chibale K
    J Med Chem; 2018 Jul; 61(13):5692-5703. PubMed ID: 29889526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum.
    Miura T; Hidaka K; Azai Y; Kashimoto K; Kawasaki Y; Chen SE; de Freitas RF; Freire E; Kiso Y
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1698-701. PubMed ID: 24631188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Girolline: a potential lead structure for antiplasmodial drug research.
    Benoit-Vical F; Saléry M; Soh PN; Ahond A; Poupat C
    Planta Med; 2008 Mar; 74(4):438-44. PubMed ID: 18484539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay.
    Lucumi E; Darling C; Jo H; Napper AD; Chandramohanadas R; Fisher N; Shone AE; Jing H; Ward SA; Biagini GA; DeGrado WF; Diamond SL; Greenbaum DC
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3597-604. PubMed ID: 20547797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel synthetic route for antimalarial benzo[a]phenoxazine derivative SSJ-183 and two active metabolites.
    Mizukawa Y; Ge JF; Bakar Md A; Itoh I; Scheurer C; Wittlin S; Brun R; Matsuoka H; Ihara M
    Bioorg Med Chem; 2014 Jul; 22(14):3749-52. PubMed ID: 24856305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imidazolopiperazines: hit to lead optimization of new antimalarial agents.
    Wu T; Nagle A; Kuhen K; Gagaring K; Borboa R; Francek C; Chen Z; Plouffe D; Goh A; Lakshminarayana SB; Wu J; Ang HQ; Zeng P; Kang ML; Tan W; Tan M; Ye N; Lin X; Caldwell C; Ek J; Skolnik S; Liu F; Wang J; Chang J; Li C; Hollenbeck T; Tuntland T; Isbell J; Fischli C; Brun R; Rottmann M; Dartois V; Keller T; Diagana T; Winzeler E; Glynne R; Tully DC; Chatterjee AK
    J Med Chem; 2011 Jul; 54(14):5116-30. PubMed ID: 21644570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procainamide-SAHA Fused Inhibitors of hHDAC6 Tackle Multidrug-Resistant Malaria Parasites.
    Nardella F; Halby L; Dobrescu I; Viluma J; Bon C; Claes A; Cadet-Daniel V; Tafit A; Roesch C; Hammam E; Erdmann D; Mairet-Khedim M; Peronet R; Mecheri S; Witkowski B; Scherf A; Arimondo PB
    J Med Chem; 2021 Jul; 64(14):10403-10417. PubMed ID: 34185525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Structure-Activity Relationship of Dual-Stage Antimalarial Pyrazolo[3,4-
    Eagon S; Hammill JT; Sigal M; Ahn KJ; Tryhorn JE; Koch G; Belanger B; Chaplan CA; Loop L; Kashtanova AS; Yniguez K; Lazaro H; Wilkinson SP; Rice AL; Falade MO; Takahashi R; Kim K; Cheung A; DiBernardo C; Kimball JJ; Winzeler EA; Eribez K; Mittal N; Gamo FJ; Crespo B; Churchyard A; García-Barbazán I; Baum J; Anderson MO; Laleu B; Guy RK
    J Med Chem; 2020 Oct; 63(20):11902-11919. PubMed ID: 32945666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimalarials with Benzothiophene Moieties as Aminoquinoline Partners.
    Konstantinović J; Videnović M; Srbljanović J; Djurković-Djaković O; Bogojević K; Sciotti R; Šolaja B
    Molecules; 2017 Feb; 22(3):. PubMed ID: 28245583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical and drug metabolism characterization of a series of 4-aminoquinoline-3-hydroxypyridin-4-one hybrid molecules with antimalarial activity.
    Thelingwani R; Bonn B; Chibale K; Masimirembwa C
    Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1313-24. PubMed ID: 25219629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a softfocus kinase library: part 2.
    Le Manach C; Paquet T; Gonzàlez Cabrera D; Younis Y; Taylor D; Wiesner L; Lawrence N; Schwager S; Waterson D; Witty MJ; Wittlin S; Street LJ; Chibale K
    J Med Chem; 2014 Nov; 57(21):8839-48. PubMed ID: 25313449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.
    Ramachandran S; Hameed P S; Srivastava A; Shanbhag G; Morayya S; Rautela N; Awasthy D; Kavanagh S; Bharath S; Reddy J; Panduga V; Prabhakar KR; Saralaya R; Nanduri R; Raichurkar A; Menasinakai S; Achar V; Jiménez-Díaz MB; Martínez MS; Angulo-Barturen I; Ferrer S; Sanz LM; Gamo FJ; Duffy S; Avery VM; Waterson D; Lee MC; Coburn-Flynn O; Fidock DA; Iyer PS; Narayanan S; Hosagrahara V; Sambandamurthy VK
    J Med Chem; 2014 Aug; 57(15):6642-52. PubMed ID: 25007124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.
    Hameed P S; Chinnapattu M; Shanbag G; Manjrekar P; Koushik K; Raichurkar A; Patil V; Jatheendranath S; Rudrapatna SS; Barde SP; Rautela N; Awasthy D; Morayya S; Narayan C; Kavanagh S; Saralaya R; Bharath S; Viswanath P; Mukherjee K; Bandodkar B; Srivastava A; Panduga V; Reddy J; Prabhakar KR; Sinha A; Jiménez-Díaz MB; Martínez MS; Angulo-Barturen I; Ferrer S; Sanz LM; Gamo FJ; Duffy S; Avery VM; Magistrado PA; Lukens AK; Wirth DF; Waterson D; Balasubramanian V; Iyer PS; Narayanan S; Hosagrahara V; Sambandamurthy VK; Ramachandran S
    J Med Chem; 2014 Jul; 57(13):5702-13. PubMed ID: 24914738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Novel
    Li R; Ling D; Tang T; Huang Z; Wang M; Ding Y; Liu T; Wei H; Xu W; Mao F; Zhu J; Li X; Jiang L; Li J
    J Med Chem; 2021 Feb; 64(4):2254-2271. PubMed ID: 33541085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.